XML 52 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting (Tables)
9 Months Ended
Mar. 31, 2022
Segment Reporting  
Segment financial information

Three Months Ended

Nine Months Ended

March 31, 

March 31, 

    

2022

    

2021

2022

    

2021

(In thousands)

(In thousands)

Consolidated revenue:

  

 

  

  

 

  

BioPharma

$

13,862

$

5,127

$

42,388

$

18,091

Consumer Health

 

10,337

 

8,356

 

26,833

 

24,059

Consolidated revenue

$

24,199

$

13,483

$

69,221

$

42,150

Consolidated net loss:

 

  

 

  

 

  

 

  

BioPharma

$

(52,311)

$

(23,570)

$

(88,359)

$

(34,788)

Consumer Health

 

(762)

 

(1,890)

 

(4,113)

 

(4,503)

Consolidated net loss

$

(53,073)

$

(25,460)

$

(92,472)

$

(39,291)

March 31, 

June 30, 

2022

2021

(In thousands)

Total assets:

BioPharma

$

139,127

$

236,449

Consumer Health

 

29,699

 

29,219

Consolidated assets

$

168,826

$

265,668